Associate Professor Nada Hamad

A/Prof Hamad is a senior staff specialist clinical and laboratory haematologist and director of the haematology clinical trials unit at the Kinghorn Cancer Centre. She has joint fellowships from the Royal Australasian College of Physicians and the Royal College of Pathologists Australasia. A/Prof Hamad’s expertise includes malignant haematology, bone marrow transplantation and CAR-T therapy. She has completed two post-graduate fellowships in haematopoietic stem cell transplantation and lymphoma from the Princess Margaret Cancer Centre in Toronto Canada. A/Prof Hamad has an interest in clinical trials and has a specialist certificate in clinical research (Oncology) from the University of Melbourne. She has developed a broad clinical trials portfolio in lymphoma, myelofibrosis, graft versus host disease and CAR-T therapy including phase 1 studies at the Kinghorn Cancer centre. She believes that clinical trials are key to offering patients cutting edge treatments in haematological cancer. She is a national and world leader in the field of bone marrow transplantation and cellular therapies and is working on delivering cutting edge research in Australia by collaborating with international colleagues and networks. She has an interest in haematology education, training and mentorship and is an RACP examiner. She is an advocate for health care improvement for vulnerable groups including rural regional patients, women and the elderly. She conducts an outreach haematology clinic at Griffith base hospital. She has a research interest in delivering holistic cancer care addressing gender specific needs in cancer care. She is an advocate and leader in the field of gender equity, diversity and inclusion in clinical care, research and health care service development.

Some of her other appointments include:

  • President of Australia and New Zealand Transplant and Cellular Therapies
  • Chair of the Agency of Clinical Innovation NSW Bone Marrow Transplant and Cellular Therapies network
  • Chair of Australasian Leukaemia and lymphoma Bone Marrow Transplant and Cellular Therapies Group
  • Australian Representative on the World Bone Marrow Transplant Society
  • Chair of the National Institute of Health International Graft versus Host Disease Group
  • Chair of St Vincent’s Hospital Sydney Medical Staff Council
  • Adjunct Associate Professor at the University of Notre Dame Australia
  • Conjoint Senior Lecturer the University of New South Wales
  • Deputy co-Chair of the Medicine Equity Diversity Inclusion Committee at the University of New South Wales
  • Lancet Haematology lead editor in equity, diversity and inclusion.

She is a member of:

  • The Australian Leukaemia and Lymphoma Group (ALLG)
  • The Haematology Society of Australasia and New Zealand (HSANZ)
  • Australia and New Zealand Transplant and Cellular Therapies (ANZTCT)
  • The American Society of Haematology (ASH)
  • The European Society of Haematology (EHA)
  • The American Society of Bone Marrow Transplantation
  • The European Society of Bone Marrow Transplantation